Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

Similar articles for PubMed (Select 20977743)

1.

IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma.

White CD, Khurana H, Gnatenko DV, Li Z, Odze RD, Sacks DB, Schmidt VA.

BMC Gastroenterol. 2010 Oct 26;10:125. doi: 10.1186/1471-230X-10-125.

2.

Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes.

Xia FD, Wang ZL, Chen HX, Huang Y, Li JD, Wang ZM, Li XY.

Asian Pac J Cancer Prev. 2014;15(12):4951-6.

3.

Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent.

Schmidt VA, Chiariello CS, Capilla E, Miller F, Bahou WF.

Mol Cell Biol. 2008 Mar;28(5):1489-502. doi: 10.1128/MCB.01090-07. Epub 2008 Jan 7.

4.

Transcript profiling identifies iqgap2(-/-) mouse as a model for advanced human hepatocellular carcinoma.

Gnatenko DV, Xu X, Zhu W, Schmidt VA.

PLoS One. 2013 Aug 12;8(8):e71826. doi: 10.1371/journal.pone.0071826. eCollection 2013.

5.

IQGAP2 inactivation through aberrant promoter methylation and promotion of invasion in gastric cancer cells.

Jin SH, Akiyama Y, Fukamachi H, Yanagihara K, Akashi T, Yuasa Y.

Int J Cancer. 2008 Mar 1;122(5):1040-6.

PMID:
17957782
6.

SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation.

Acun T, Oztas E, Yagci T, Yakicier MC.

BMC Cancer. 2011 Jun 6;11:223. doi: 10.1186/1471-2407-11-223.

7.

Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.

Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.

Gastroenterology. 2008 Dec;135(6):2128-40, 2140.e1-8. doi: 10.1053/j.gastro.2008.07.027. Epub 2008 Jul 31.

PMID:
18801366
8.

YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?

Xiao XQ, Hassanein T, Li QF, Liu W, Zheng YH, Chen J.

Hepatobiliary Pancreat Dis Int. 2011 Dec;10(6):605-10.

9.

Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.

Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.

Clin Cancer Res. 2002 Apr;8(4):1087-92.

10.

Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.

Sun JZ, Yang XX, Li XH, Xu WW, Wang Y, Zhu W, Li M.

Dig Dis Sci. 2011 Oct;56(10):3072-7. doi: 10.1007/s10620-011-1686-y. Epub 2011 Mar 30.

PMID:
21448695
11.

Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.

Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.

Genes Chromosomes Cancer. 2009 Dec;48(12):1057-68. doi: 10.1002/gcc.20708.

PMID:
19760608
12.

Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.

Qiu W, David D, Zhou B, Chu PG, Zhang B, Wu M, Xiao J, Han T, Zhu Z, Wang T, Liu X, Lopez R, Frankel P, Jong A, Yen Y.

Am J Pathol. 2003 Jun;162(6):1961-74.

13.

[Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].

Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.

Zhonghua Zhong Liu Za Zhi. 2008 Nov;30(11):831-6. Chinese.

PMID:
19173828
14.

Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma.

Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Hishida M, Suenaga M, Yamada S, Inokawa Y, Nishikawa Y, Asai M, Fujii T, Sugimoto H, Kodera Y.

Int J Oncol. 2014 Jan;44(1):44-52. doi: 10.3892/ijo.2013.2165. Epub 2013 Nov 5.

PMID:
24189587
15.

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.

Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.

Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7.

PMID:
19898900
16.

Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.

Shih YL, Shyu RY, Hsieh CB, Lai HC, Liu KY, Chu TY, Lin YW.

Cancer. 2006 Aug 1;107(3):579-90.

17.

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.

Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.

Oncogene. 2000 Nov 2;19(46):5298-302.

18.

Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.

Zhang X, Li N, Li X, Zhao W, Qiao Y, Liang L, Ding Y.

J Gastroenterol Hepatol. 2012 Jun;27(6):1117-25. doi: 10.1111/j.1440-1746.2011.07049.x.

PMID:
22168621
19.

Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.

Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.

Clin Cancer Res. 2008 Nov 15;14(22):7405-12. doi: 10.1158/1078-0432.CCR-08-0409.

20.

Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.

Li Z, Zhang H, Yang J, Hao T, Li S.

Cell Biol Int. 2012 May 1;36(5):427-32. doi: 10.1042/CBI20100851.

PMID:
21864295
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk